EMEA-003426-PIP01-23

EMA traineeship programme informative session, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 April 2025, 10:00 (CEST) to 14 April 2025, 11:00 (CEST)

Veterinary medicines European public assessment report (EPAR): Leucofeligen FeLV/RCP, feline calicivirosis, feline viral rhinotrachieitis, feline infectious enteritis (feline panleucopenia) vaccine (live), feline leukaemia vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Cimalgex, cimicoxib, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Cytopoint, lokivetmab, Status: Authorised

Human medicines European public assessment report (EPAR): Steglatro, ertugliflozin, Date of authorisation: 21/03/2018, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Skilarence, dimethyl fumarate, Date of authorisation: 23/06/2017, Revision: 13, Status: Authorised

European Organisation for Research and Treatment of Cancer (EORTC) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 9 April 2025

Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Date of authorisation: 13/07/2011, Revision: 58, Status: Authorised

EMEA-003389-PIP01-23